Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

Celgene’s Revlimid scores NICE approval in follicular lymphoma

Celgene’s Revlimid scores NICE approval in follicular lymphoma According to Celgene, this approval opens the treatment up to over 600 patients in England, who were previously limited to clinical trials or palliative care. ... The approval came only a short time after Bristol-Myers Squibb completed its $74bn

Can protein degraders unlock ‘undruggable’ drug targets?

Can protein degraders unlock ‘undruggable’ drug targets? In 2015, Celgene signed up with Nurix for a project to find drugs that may improve the immune response to cancer. ... merger with Celgene goes through later this year.

GSK pays $50m upfront to tap Immatics’ cell therapy platform

GSK pays $50m upfront to tap Immatics’ cell therapy platform Deal focuses on T cell receptor therapies

AbbVie/Allergan merger faces renewed public opposition despite divestments

AbbVie/Allergan merger faces renewed public opposition despite divestments Given the hurdles Bristol-Myers Squibb and Celgene were required to jump over, it seems probable that the renewed public opposition could hurt AbbVie/Allergan’s chances with the FTC.

FDA begins speedy review of BMS’ CAR-T liso-cel

FDA begins speedy review of BMS’ CAR-T liso-cel BMS acquired liso-cel following its $74bn takeover of Celgene, and is one of the drugs critical to the potential payout of the merger in contingent value rights. ... Prior to the takeover, Celgene had forecast that liso-cel could become a $3bn product,

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...